Rituxem 100 mg Injection
  1. Home
  2. Pharma Products
  3. Emcure Pharmaceuticals Ltd
  4. Rituxem 100 mg Injection

Rituxem 100 mg Injection

Rituxem 100 mg Injection contains rituximab and is a monoclonal antibody medicine used for certain blood cancers and autoimmune conditions. It works by targeting CD20-positive B cells and helping the immune system remove abnormal cells. The medicine is administered by intravenous infusion under the supervision of a qualified healthcare professional.

BUY NOW

Category

Rituximab binds to the CD20 protein on B cells and supports their destruction through immune-mediated mechanisms. Rituxem 100 mg Injection is used in treatment regimens for conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukemia, and selected autoimmune disorders. The 100 mg presentation is supplied as a concentrated solution that requires appropriate dilution before intravenous administration. Patients may require monitoring for infusion reactions, infections, blood count changes, and other treatment-related effects.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 100 mg
Concentration 10 mg/mL
Fill Volume 10 mL
Dosage Form Injection
Route of Administration Intravenous infusion

Product Also Known As

Rituxem 100 mg, Rituxem 100 mg Injection, Rituxem 100 mg/10 mL, Rituximab 100 mg Injection, Rituximab 100 mg/10 mL, Rituximab Injection, Anti-CD20 Monoclonal Antibody